Dr. Shook is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1975 4th St
San Francisco, CA 94143Phone+1 415-476-1000
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Johns Hopkins UniversityResidency, Pediatrics, 2004 - 2007- Johns Hopkins University School of MedicineClass of 2004
Purdue UniversityBS, Biology, Distinction; Honors Degree, 1996 - 2000
Certifications & Licensure
CA State Medical License 2020 - 2026
FL State Medical License 2015 - 2021
TN State Medical License 2007 - 2015- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors Start of enrollment: 2008 Sep 01
- Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2009 Oct 01
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas Start of enrollment: 2012 Aug 20
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsProgenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss.James E. Baumgartner, Linda S. Baumgartner, Michael E. Baumgartner, Ernest J. Moore, Steven A. Messina
Stem Cells Translational Medicine. 2021-02-01 - 6 citationsAutologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional ...Aimee C Talleur, Jamie E. Flerlage, David Shook, Abigail M Chilsen, Melissa M. Hudson
Bone Marrow Transplantation. 2020-04-09 - 14 citationsSafety of Autologous Umbilical Cord Blood Therapy for Acquired Sensorineural Hearing Loss in Children.Linda S. Baumgartner, Ernest J. Moore, David Shook, Steven A. Messina, Mary Clare Day
Journal of Audiology & Otology. 2018-08-22
Journal Articles
- Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell DepletionBrandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease
Press Mentions
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
